Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 86
Healthy volunteers: no

Brief summary:
This trial is conducted in Europe. The aim of the trial is to compare insulin detemir once daily to NPH insulin once daily as measured by blood sugar control in ageing subjects with type 2 diabetes naive to previous insulin therapy.

Detailed description:
Novo Nordisk has decided to discontinue the trial as it will not be possible to recruit the required number of patients. The discontinuation is based on an analysis of the significant delay in recruitment of patients which is likely to have a negative impact on the validity of the trial.

Arms:
arm 1: Individually adjusted dose of insulin detemir once daily arm 2: Individually adjusted dose of insulin NPH once daily

Interventions: intervention 1: insulin detemir intervention 2: insulin NPH
Intervention descriptions: intervention 1: Treat-to-target, s.c. (under the skin) injection, once daily intervention 2: Treat-to-target, s.c. (under the skin) injection, once daily

Protocol document: